Literature DB >> 25445772

Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.

Ankit V Patel1, James B Wade2, Leroy R Thacker3, Richard K Sterling1, Muhammad S Siddiqui1, R Todd Stravitz1, Arun J Sanyal1, Velimir Luketic1, Puneet Puri1, Michael Fuchs1, Scott Matherly1, Melanie B White1, Ariel Unser1, Douglas M Heuman1, Jasmohan S Bajaj4.   

Abstract

BACKGROUND & AIMS: Covert hepatic encephalopathy (CHE) is associated with cognitive dysfunction, which affects daily function and health-related quality of life (HRQOL) in patients with cirrhosis. The effects of CHE and liver disease are determined by cognitive reserve—the ability of the brain to cope with increasing damage while continuing to function—and are assessed by composite intelligence quotient (IQ) scores. We examined cognitive reserve as a determinant of HRQOL in patients with cirrhosis.
METHODS: We performed a prospective study of 118 outpatients with cirrhosis without overt HE (age, 56 y). We studied cognition using the standard paper-pencil battery; patients with below-normal results for more than 2 tests were considered to have CHE. We also assessed HRQOL (using the sickness impact profile [SIP]), psychosocial and physical scores (a high score indicates reduced HRQOL), model for end-stage liver disease (MELD) scores, and cognitive reserve (using the Barona Index, a validated IQ analysis, based on age, race, education, residence area, and occupation). Cognitive reserve was divided into average and high groups (<109 or >109), and MELD and SIP scores were compared. We performed regression analyses, using total SIP score and psychosocial and physical dimensions as outcomes, with cognitive reserve, CHE, and MELD score as predictors.
RESULTS: Study participants had average MELD scores of 9, and 14 years of education; 81% were white, 63% were urban residents, their mean IQ was 108 ± 8, and 54% had average cognitive reserve (the remaining 46% had high reserves). CHE was diagnosed in 49% of patients. Cognitive reserve was lower in patients with CHE (109) than without (105; P = .02). Cognitive reserve correlated with total SIP and psychosocial score (both r = -0.4; P < .001) and physical score (r = -0.3; P = .01), but not MELD score (P = .8). Patients with high cognitive reserve had a better HRQOL, despite similar MELD scores. In regression analyses, cognitive reserve was a significant predictor of total SIP (P < .001), psychosocial (P < .001), and physical scores (P < .03), independent of CHE, MELD, or psychiatric disorders.
CONCLUSIONS: A higher cognitive reserve is associated with a better HRQOL in patients with cirrhosis, despite similar disease severity and prevalence. This indicates that patients with good cognitive reserve are better able to withstand the demands of cirrhosis progression and CHE, leading to a better HRQOL. Patients with lower cognitive reserve may need more dedicated and earlier measures to improve HRQOL. Cognitive reserve should be considered when interpreting HRQOL and cognitive tests to evaluate patients with cirrhosis.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coping; Daily Function; Intelligence Quotient; Minimal Hepatic Encephalopathy; Prognostic Factor

Mesh:

Year:  2014        PMID: 25445772      PMCID: PMC4404167          DOI: 10.1016/j.cgh.2014.09.049

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  27 in total

1.  In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009.

Authors:  Maria Stepanova; Alita Mishra; Chapy Venkatesan; Zobair M Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2012-05-27       Impact factor: 11.382

Review 2.  Covert hepatic encephalopathy: not as minimal as you might think.

Authors:  Matthew R Kappus; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

Review 3.  Multidisciplinary management of patients with cirrhosis: a need for care coordination.

Authors:  Jessica L Mellinger; Michael L Volk
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-06       Impact factor: 11.382

4.  Factors associated with poor health-related quality of life of patients with cirrhosis.

Authors:  G Marchesini; G Bianchi; P Amodio; F Salerno; M Merli; C Panella; C Loguercio; G Apolone; M Niero; R Abbiati
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

Review 5.  Quality of life in cirrhotics with minimal hepatic encephalopathy.

Authors:  H Schomerus; W Hamster
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

6.  Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients.

Authors:  Silvia Nardelli; Ilaria Pentassuglio; Chiara Pasquale; Lorenzo Ridola; Federica Moscucci; Manuela Merli; Concetta Mina; Massimo Marianetti; Mariangela Fratino; Chiara Izzo; Carlo Merkel; Oliviero Riggio
Journal:  Metab Brain Dis       Date:  2013-01-08       Impact factor: 3.584

7.  The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers.

Authors:  Jasmohan S Bajaj; James B Wade; Douglas P Gibson; Douglas M Heuman; Leroy R Thacker; Richard K Sterling; R Todd Stravitz; Velimir Luketic; Michael Fuchs; Melanie B White; Debulon E Bell; HoChong Gilles; Katherine Morton; Nicole Noble; Puneet Puri; Arun J Sanyal
Journal:  Am J Gastroenterol       Date:  2011-05-10       Impact factor: 10.864

8.  Estimating premorbid functioning in huntington's disease: the relationship between disease progression and the wide range achievement test reading subtest.

Authors:  Justin J F O'Rourke; William H Adams; Kevin Duff; Joanne Byars; Peg Nopoulos; Jane S Paulsen; Leigh J Beglinger
Journal:  Arch Clin Neuropsychol       Date:  2010-12-08       Impact factor: 2.813

9.  Cognitive reserve and patient-reported outcomes in multiple sclerosis.

Authors:  Carolyn E Schwartz; Erin Snook; Brian Quaranto; Ralph H B Benedict; Timothy Vollmer
Journal:  Mult Scler       Date:  2012-04-30       Impact factor: 6.312

10.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

View more
  13 in total

1.  The etiology of cirrhosis is a strong determinant of brain reserve: A multimodal magnetic resonance imaging study.

Authors:  Vishwadeep Ahluwalia; James B Wade; F Gerard Moeller; Melanie B White; Ariel B Unser; Edith A Gavis; Richard K Sterling; R Todd Stravitz; Arun J Sanyal; Mohammad S Siddiqui; Puneet Puri; Velimir Luketic; Douglas M Heuman; Michael Fuchs; Scott Matherly; Jasmohan S Bajaj
Journal:  Liver Transpl       Date:  2015-07-21       Impact factor: 5.799

2.  An association between dietary habits and traffic accidents in patients with chronic liver disease: A data-mining analysis.

Authors:  Takumi Kawaguchi; Takuro Suetsugu; Shyou Ogata; Minami Imanaga; Kumiko Ishii; Nao Esaki; Masako Sugimoto; Jyuri Otsuyama; Ayu Nagamatsu; Eitaro Taniguchi; Minoru Itou; Tetsuharu Oriishi; Shoko Iwasaki; Hiroko Miura; Takuji Torimura
Journal:  Biomed Rep       Date:  2016-03-23

3.  Liver transplantation significantly improves global functioning and cerebral processing.

Authors:  Vishwadeep Ahluwalia; James B Wade; Melanie B White; HoChong S Gilles; Douglas M Heuman; Michael Fuchs; Edith A Gavis; Andrew Fagan; Felicia Tinsley; Dinesh Ganapathy; Leroy R Thacker; Richard K Sterling; R Todd Stravitz; Puneet Puri; Arun J Sanyal; Muhammad S Siddiqui; Scott Matherly; Velimir Luketic; Joel Steinberg; F Gerard Moeller; Jasmohan S Bajaj
Journal:  Liver Transpl       Date:  2016-10       Impact factor: 5.799

4.  Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index.

Authors:  Elliot B Tapper; Monica Konerman; Susan Murphy; Christopher J Sonnenday
Journal:  Am J Transplant       Date:  2018-08-13       Impact factor: 8.086

5.  Cognitive reserve is a resilience factor for cognitive dysfunction in hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Giuseppe Spinelli; Sami Schiff; Daniela Mapelli
Journal:  Metab Brain Dis       Date:  2017-06-02       Impact factor: 3.584

6.  Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis.

Authors:  Jasmohan S Bajaj; Michael Ellwood; Timothy Ainger; Thomas Burroughs; Andrew Fagan; Edith A Gavis; Douglas M Heuman; Michael Fuchs; Binu John; James B Wade
Journal:  Clin Transl Gastroenterol       Date:  2017-07-27       Impact factor: 4.488

Review 7.  Cognitive Function in Liver Transplantation.

Authors:  Somaya A M Albhaisi; Jasmohan S Bajaj
Journal:  Curr Transplant Rep       Date:  2020-03-26

8.  Effects of erythropoietin on bile duct ligation-induced neuro-inflammation in male rats.

Authors:  Moazameh Golshani; Mohsen Basiri; Mohammad Shabani; Iraj Aghaei; Majid Asadi-Shekaari
Journal:  AIMS Neurosci       Date:  2019-04-29

Review 9.  Hepatic Encephalopathy: From Metabolic to Neurodegenerative.

Authors:  Rafael Ochoa-Sanchez; Farzaneh Tamnanloo; Christopher F Rose
Journal:  Neurochem Res       Date:  2021-06-15       Impact factor: 3.996

Review 10.  Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues.

Authors:  Sara Montagnese; Jasmohan S Bajaj
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.